CoreAge Rx vs VevaRX

The verdict

CoreAge Rx edges out VevaRX on the Mom-Tested Score, 94 to 52 (A vs C). Moms who want a flat, no-teaser price, both molecules available, and a signup you can genuinely finish while the baby sleeps — without a phone-tag scheduling loop.

VevaRX is still a genuine option — its own semaglutide page gives two different prices for the same product. The pricing cards read $189 a month or $399 for three months, and the paragraph directly beneath them reads $167 a month or $467 for three — and since $467 is the tirzepatide total, that text looks like leftover copy from the other product. The tirzepatide page has an arithmetic problem of its own, advertising $467 as equivalent to $149 a month when three months at $467 is $155.67, and there is no monthly tirzepatide plan at all: three months is the minimum and it renews every three months. The terms then make it worse by referring repeatedly to a different company's website and listing prices matching nothing on the product pages. What is genuinely strong gets lost underneath all that. VevaRX lists thirty-six states by name rather than claiming fifty, it locks the price before intake and holds it at every dose, and the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping. Weigh the six mom factors below against your own priorities.